(Q39988114)

16 September 2017

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma (English)

1 reference

16 September 2017

Ke Pan

1

1 reference

16 September 2017

Hui Wang

2

1 reference

16 September 2017

Min-shan Chen

3

1 reference

16 September 2017

Hua-kun Zhang

4

1 reference

16 September 2017

De-sheng Weng

5

1 reference

16 September 2017

Jun Zhou

6

1 reference

16 September 2017

Wei Huang

7

1 reference

16 September 2017

Jian-jun Li

8

1 reference

16 September 2017

Hai-feng Song

9

1 reference

16 September 2017

Jian-chuan Xia

10

1 reference

16 September 2017

26 April 2008

1 reference

Journal of Cancer Research and Clinical Oncology

16 September 2017

1 reference

16 September 2017

134

1 reference

16 September 2017

11

1 reference

16 September 2017

1247-1253

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-008-0395-1

16 September 2017

0 references

cites work

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0395-1

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

12 December 2020

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

12 December 2020

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

12 December 2020

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

12 December 2020

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

1 reference

12 December 2020

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

12 December 2020

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

12 December 2020

Estimating the world cancer burden: Globocan 2000.

1 reference

12 December 2020

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

12 December 2020

Inflammation and cancer

1 reference

12 December 2020

Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma.

1 reference

12 December 2020

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

12 December 2020

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

12 December 2020

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

1 reference

12 December 2020

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

1 reference

12 December 2020

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer

1 reference

12 December 2020

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

12 December 2020

Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase

1 reference

12 December 2020

Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.

1 reference

12 December 2020

Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes

1 reference

12 December 2020

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

1 reference

12 December 2020

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

1 reference

12 December 2020

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

12 December 2020

When ligand becomes receptor--tolerance via B7 signaling on DCs

1 reference

12 December 2020

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

1 reference

12 December 2020

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.

1 reference

12 December 2020

10.1007/S00432-008-0395-1

Identifiers

DOI

1 reference

16 September 2017

1 reference